In a study on AML patient cohort, high-throughput resequencing revealed genetic alterations in IDH1, IDH2, and TET2 with frequencies of 6.2%, 8.6%, and 7.3%, respectively [35]. The gene discussed is TET2; the disease is acute myeloid leukemia.